European Collaboration Diagnoses 500 Rare Disease Patients via Advanced Genetic Research
The European consortium Solve-RD provided genetic diagnoses for rare disease patients, highlighting the power of international collaboration.
The European consortium Solve-RD provided genetic diagnoses for rare disease patients, highlighting the power of international collaboration.
In this episode of Clinical Lab Chat, Seth Egan of Co-Diagnostics discusses how POC testing improves both diagnostic and treatment access.
In this episode of Clinical Lab Chat, we presented the CEO of Senzo a challenge—is it possible to create a “perfect” diagnostic test?
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.
Read MoreIn this episode of Clinical Lab Chat, CLP’s Chris Wolski interviews BD’s Bridget Bagnato about the company’s new MiniDraw technology.
Read MoreThe newly launched Cancer Screening Research Network (CSRN) will evaluate promising and emerging cancer screening technologies.
Read MoreCLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read MorePanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read MoreThis research could help address challenges in misdiagnosis and treatment of patients, potentially reducing bleeding complication risks.
Read MoreIn this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, engaged in a deep-dive discussion on the burgeoning synergy between omics technologies and precision medicine solutions with Rosy Lee, VP and general manager, Life Sciences Mass Spectrometry, Thermo Fisher Scientific.
Read MoreCLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include using urine to identify breast cancer biomarkers; the distinctions between mammographies and liquid biopsies for cancer detection; and more.
Read MoreDiscover the latest insights on food allergies in the U.S. on Clinical Lab Chat! Join Chris Wolski, CLP’s Director of Business Intelligence, in a conversation with Jessica Murphy, MLS(ASCP)CM, from Thermo Fisher Scientific. They delve into:
The surge in food allergies among Americans and its causes.
The game-changing impact of home testing on allergy detection (and its challenges).
The crucial role of primary care doctors in allergy testing.
The promise of precise allergy testing for better patient care.
Why clinical labs remain vital for allergy diagnostics.
A glimpse into the future of allergy testing in the next 5-10 years. Don’t miss it!
XiFin has added new features and insights to its Lab Volume Index (LVI), with a deeper dive in the post-pandemic diagnostic landscape.
Read MoreIn its second annual Wage and Morale Survey, Lighthouse Lab Services found improvements in wages and satisfaction, but more can be done.
Read MoreLearn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Read MoreChris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today.
Read MoreChris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care.
Read MoreIn this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home testing improves healthcare access, and the win-win-win it brings to clinical laboratories.
Read More